Search results :

Oxybutynin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: G04BD04

Side effects

Options: Hide MedDRA Preferred Terms ,   display all 43 labels

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Gastrointestinal disorder Gastrointestinal disorder postmarketing, 71.4% x x x x x x x x x
Constipation Constipation common, 0% - 15.1% 0% x x x x
Dry mouth Dry mouth common, 0.7% - 72.4% 1.7% - 8.3% x x x x x x x x x x x x x x x x x x x x
Headache Headache common, 1.5% - 8% x x x x x x x x x x x x x x x x
Infection Infection 6.5% x x x x x x x
Diarrhoea Diarrhoea common, 2.3% - 7.9% 2.3% x x x x x x x x x x x x x x x x
Loose stools 1.4% - 3% x x x x x x
Nervousness Nervousness 1.5% - 6.5% x x x x x x x x x
Tension Nervousness 1.5% - 6.5% x x x x x x x x x
Tension x
Urinary tract infection Urinary tract infection 5.2% - 6.94% 4.25% x x x x x x x x x x x x x
Infestation Infestation NOS 6.5% x x x x x x x
Application site erythema Application site erythema common, 1.7% - 10% 0.99% - 2.3% x x x x
Somnolence Somnolence postmarketing — 5.6% - 14.1% x x x x x x x x x x x x x
Drowsiness x x x x
Urinary hesitation Urinary hesitation 1.9% - 8.5% x x x x x x x
Dyspepsia Dyspepsia uncommon, 4.5% - 6% x x x x x x x x x x x
Nausea Nausea common, 1.9% - 11.6% x x x x x x x x x x x x x x x x
Application site pruritus Application site pruritus 2.1% - 16.8% x x x x
Dizziness Dizziness postmarketing — 1.5% - 16.6% 1% x x x x x x x x x x x x x x x x x x
Syncope x x
Application site reaction Application site reaction common x x x x
Vision blurred Vision blurred common, 2.3% - 9.6% x x x x x x x x x x x x x x x
Insomnia Insomnia 2.8% - 5.5% x x x x x x x x x x x x x x
Nasal dryness Nasal dryness 1.7% - 4.5% x x x x x x x x x x x
Dry eye Keratoconjunctivitis sicca 2.5% - 4.2% x x
Dry eye 2.5% - 3.1% x x x x x x x x x x
Application site rash Application site rash common, 0.9% - 4% 0.495% - 0.9% x x x x x
Oedema peripheral Oedema peripheral 2.5% - 4% x x x x x x x x x
Application site vesicles Application site vesicles 0% - 4% 0% x x
Asthenia Fatigue 2.06% - 3.1% 1% x x x x x x x x x x
Asthenia 1.7% - 2.5% x x x x x x x x x x x x x
Fatigue Fatigue 2.06% - 3.1% 1% x x x x x x x x x x
Urinary retention Urinary retention uncommon, 1.2% - 6% x x x x x x x x x x x
Abdominal pain upper Abdominal pain upper 3% x x
Residual urine volume Residual urine volume 2.3% - 3.5% x
Cough Cough 1.9% - 3% x x x x x x x x x x
Cough increased
Nasopharyngitis Nasopharyngitis 1.5% - 2.83% 2.25% x x x x x x x x
Upper respiratory tract infection Upper respiratory tract infection uncommon, 2.2% - 5.4% 5% x x x x x x x x x x
Dry skin Dry skin 1.8% - 3% x x x x x x x x x x x x x
Macule Macule 0% - 3% 0% x x
Visual impairment Abnormal vision 0% - 3% 0% x x
Dry throat Dry throat 1.6% - 2.5% x x x x x x x x
Viral diarrhoea Viral diarrhoea 2.06% 1.75% x
Abdominal pain Abdominal pain common, 1.5% - 2.5% x x x x x x x x x x x x x
Gastrointestinal pain Abdominal pain common, 1.5% - 2.5% x x x x x x x x x x x x x
Back pain Back pain uncommon, 2% - 2.4% x x x x x x x x x x
Dysuria Dysuria uncommon, 0% - 3% 0% x x x x x x x x x
Urination impaired x
Nasal congestion Nasal congestion 2% x x
Sinus headache Sinus headache 2% x x
Sinus congestion Sinus congestion 2% x x
Flatulence Flatulence 1.2% - 2.5% x x x x x x x x x x x x
Arthralgia Arthralgia 1.5% - 2% x x x x x x
Musculoskeletal discomfort Arthralgia 1.5% - 2% x x x x x x
Confusional state Confusional state 1% - 2.5% x x x x x x x x x x x x
Feeling abnormal Confusional state 1% - 2.5% x x x x x x x x x x x x
Malaise
Depression Depression 1.7%
Sinusitis Sinusitis 1.7% x x x x x x
Laryngeal pain Pharyngolaryngeal pain 1.5% - 1.9% x x x x x x
Oropharyngeal pain Oropharyngeal pain 1.5% - 1.9% x x
Bronchitis Bronchitis 1.2% - 2% x x x x x x x x
Dysphagia Dysphagia 1.5% x x x x x x
Dysgeusia Dysgeusia 1.1% - 1.6% x x x x x x x x x
Taste metallic x x
Palpitations Palpitations uncommon, 1.5% - 4.5% x x x x x x x x x x x x x x
Blood glucose increased Blood glucose increased 1.5% x x
Vomiting Vomiting 1.2% - 1.5% x x x x x x x x x x x
Chest pain Chest pain 1.3% x x x x x x x
Chest discomfort x x
Hypertension Hypertension 1.3% x x x x x x x x x
Pruritus Pruritus very common, 1.3% - 1.5% x x x x x x x x x x
Blood pressure increased Blood pressure increased 1% - 1.5% x x x x x x
Pain in extremity Pain in extremity 1% - 1.3% x x x x x x
Sinus arrhythmia Sinus arrhythmia 1% x x
Asthma Asthma 1% x x
Tongue coated Tongue coated 1% x x
Cystitis Cystitis 1% x x x x x x x x
Bladder pain Cystitis 1% x x x x x x x x
Cystitis noninfective Cystitis 1% x x x x x x x x
Oedema Oedema 1% x x x x
Eructation Eructation 1% x x
Flank pain Flank pain 1% x x
Gastrooesophageal reflux disease Gastrooesophageal reflux disease 0.5% - 1.6% x x x x x x x x x x
Dysphonia Hoarseness 1% x
Dysphonia x x
Hypotension Hypotension 1% x x
Fungal infection Fungal infection uncommon, 1% x x x
Pain Pain 1% x x x x x x x x
Thirst Thirst 1% x x x x
Pollakiuria Pollakiuria 1%
Micturition urgency
Eye irritation Eye irritation 1% x x
Fluid retention Fluid retention 1% x x x x
Generalised oedema
Rhinitis Rhinitis uncommon x x x x x x x
Abdominal discomfort Abdominal discomfort uncommon x x x
Injury Inflicted injury uncommon x
Accidental injury x x
Menopausal symptoms Hot flush uncommon x x x
Hot flush Hot flush uncommon x x x
Obstructive airways disorder Airway obstruction NOS postmarketing x x x x
Anaphylactic shock Anaphylactic shock postmarketing x x x x
Angioedema Angioedema postmarketing x x x x x x
Arrhythmia Arrhythmia postmarketing x x x x x x x x x
Mental disorder Mental disorder postmarketing, 5.5% x x x x x x x x
Breast disorder Breast disorder postmarketing x
Dermatitis Rash postmarketing x x x x x x x x x x x x x x
Dermatitis x
Rash Rash postmarketing x x x x x x x x x x x x x x
Eye disorder Eye disorder postmarketing, 9.6% x x x x x x
Flushing Flushing postmarketing, 1% x x x x x x x x x x x x
Glaucoma Glaucoma postmarketing x x x
Hallucination Hallucination postmarketing x x x x x x x x x x x x x
Cardiac disorder Cardiac disorder postmarketing x x x x x x x x x
Hypersensitivity Hypersensitivity postmarketing x x x x x x
Mydriasis Mydriasis postmarketing x x x x x x x x x x x x x x
Nervous system disorder Nervous system disorder postmarketing, 16.6% x x x x x x x x
Psychotic disorder Psychotic disorder postmarketing x x x x x x x
Paranoia x x
Convulsion Convulsion postmarketing x x x x x x x x x x x
Tachycardia Tachycardia postmarketing x x x x x x x x x x x x x x
Urethral disorder Urinary tract disorder postmarketing, 8.5% x x x x x x x x x
Urinary tract disorder Urinary tract disorder postmarketing, 8.5% x x x x x x x x x
Urticaria Urticaria postmarketing, uncommon x x x x x x x x
Angiopathy Angiopathy postmarketing x x x x x x x x x
Agitation Agitation postmarketing x x x x x x x x x x
Hyperkinesia
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x
Memory impairment Memory impairment postmarketing x x x x x x
Accommodation disorder Cycloplegia postmarketing x x x x x x x x x x x x x x
Cycloplegia Cycloplegia postmarketing x x x x x x x x x x x x x x
Erectile dysfunction Erectile dysfunction postmarketing x x x x x x x x x x x x x x
Face oedema Face oedema postmarketing x x x x
Hypohidrosis Sweating decreased postmarketing x x x x x x
Amblyopia Amblyopia x x x
Amnesia Amnesia
Decreased appetite Anorexia x x x x x
Anxiety Anxiety x x
Arthritis Arthritis x x
Cognitive disorder Cognitive disorder x x
Colitis Colitis
Conjunctivitis Conjunctivitis x
Connective tissue disorder Connective tissue disorder x x x x x x x
Libido decreased Libido decreased
Disturbance in sexual arousal Libido decreased
Depersonalisation Depersonalisation
Epistaxis Epistaxis x
Oesophagitis Oesophagitis
Angle closure glaucoma Angle closure glaucoma x x
Glossitis Glossitis
Hair disorder Hair disorder
Breath odour Breath odour
Heat stroke Heat stroke x
Haematuria Haematuria
Hiccups Hiccups
Hypoaesthesia Hypoaesthesia
Influenza Influenza x x
Iritis Iritis
Arthropathy Arthropathy
Osteoarthritis Arthropathy
Lung disorder Lung disorder
Mediastinal disorder Mediastinal disorder x x x x x x x x
Melaena Melaena
Hypertonia Hypertonia
Nail disorder Nail disorder
Nightmare Nightmare x x
Nocturia Nocturia
Paraesthesia Paraesthesia
Pharyngitis Pharyngitis x x
Salivary hypersecretion Salivary hypersecretion
Stomatitis Stomatitis
Mouth ulceration
Shock Syncope x x
Syncope Syncope x x
Loss of consciousness Syncope x x
Tenosynovitis Tenosynovitis
Tinnitus Tinnitus
Tongue disorder Tongue disorder
Erythema Erythema x
Urethritis Urethritis
Urethritis noninfective Urethritis
Vasodilation procedure Vasodilation x x
Micturition urgency Micturition urgency
Mood swings Mood swings x
Affect lability Mood swings x
Depressive symptom Depressive symptom x
Mouth ulceration Mouth ulceration
Migraine Migraine
Blood creatinine increased Creatinine increased
Tongue discolouration Tongue discolouration
Generalised oedema Generalised oedema
Liver function test abnormal Liver function test abnormal
Drug ineffective Lack of drug effect
Eye pain Eye pain
Urethral pain Urethral pain
Paraesthesia oral Circumoral paresthesia
Rash pustular Vesiculobullous rash
Dermatitis bullous Vesiculobullous rash
Skin discolouration Skin discolouration
Malnutrition Malnutrition x x x x
Malaise Malaise
Discomfort Malaise
Ill-defined disorder Malaise
Increased appetite Increased appetite
Thinking abnormal Thinking abnormal
Mental disability Thinking abnormal
Chest discomfort Chest discomfort x x
Lacrimation decreased Lacrimation decreased x x x
Frequent bowel movements Frequent bowel movements x x
Abdominal distension Enlargement abdomen
Bloated feeling x
Akathisia Akathisia
Hyperkinesia Hyperkinesia
Dermatitis atopic Cutaneous hypersensitivity x
Sleep disorder Sleep disorder
Application site pain Application site burn x
Application site burn Application site burn x
Hypertonic bladder Detrusor instability x
Increased upper airway secretion Increased upper airway secretion
Paranoia Paranoia x x
Ageusia Ageusia

Indications

Information about indications was extracted from the indications and usage sections of the labels.

OXYBUTYNIN

Side effects:10
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:14
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:16
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:17
Source:FDA Structured Product Label

OXYBUTYNIN / OXYTROL

Side effects:21
Source:FDA

OXYBUTYNIN CHLORIDE / PHL-OXYBUTYNIN

Side effects:28
Source:Health Canada

/ Ditropan XL Tablets

Side effects:32
Source:FDA

oxybutynin / oxybutynin

Side effects:35
Source:EMA

OXYBUTYNIN CHLORIDE / DITROPAN XL

Side effects:40
Source:FDA

Each tablet contains oxybutynin hydrochloride / DITROPAN

Side effects:41
Source:medicines.org.au

OXYBUTYNIN CHLORIDE / DITROPAN XL

Side effects:43
Source:FDA

OXYBUTYNIN

Side effects:60
Source:FDA Structured Product Label

oxybutynin

Side effects:65
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:67
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:68
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:69
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:73
Source:FDA Structured Product Label

oxybutynin

Side effects:76
Source:FDA Structured Product Label

OXYBUTYNIN

Side effects:80
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label